MARKET INTRODUCTION

Metagenomic sequencing is running all nucleic acids in a sample that contain mixed populations of microorganisms. They are used to assign their reference genomes, which helps understand which microbes are present and in what proportions of the sample under study.

MARKET DYNAMICS

The metagenomics sequencing market growth is expected to grow faster due to increasing applications of metagenomics in the drug development, and clinical diagnostics. The growing awareness and knowledge about the benefits of metagenomics is likely to enhance growth opportunities for the market growth during the forecast years.

MARKET SCOPE

The "Metagenomics Sequencing Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of metagenomics sequencing market with detailed market segmentation by product and service, technology, and application. The metagenomics sequencing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in metagenomics sequencing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The metagenomics sequencing market is segmented on the basis of product and service, technology, and application. Based on product and service, the market is divided into instruments, reagents and consumables, and software and service. Based on technology, the market is classified as shotgun metagenomic sequencing, RNA sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics. And based on drug discovery, clinical diagnostics, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the metagenomics sequencing market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The metagenomics sequencing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting metagenomics sequencing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the metagenomics sequencing market in these regions.

MARKET PLAYERS

The report covers key developments in the metagenomics sequencing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from metagenomics sequencing market are anticipated to have lucrative growth opportunities in the future with the rising demand for metagenomics sequencing in the global market. Below mentioned is the list of few companies engaged in the metagenomics sequencing market.

The report also includes the profiles of key players in metagenomics sequencing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Perkinelmer Inc.
- Illumina Inc.
- DNAstar, Inc.
- QIAGEN N.V.
- Eurofins Scientific
- Integragen SA
- Novogene Co., Ltd.
- Macrogen, Inc.
- Oxford Nanopore Technologies, Ltd.
- BGI Group